111

GREEN CROSS MEDICAL SCIENCE CORPORATION

No trades
See on Supercharts

142280 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Green Cross Medical Science Corp. engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies. It operates through following business divisions: Diagnostic Reagents, Hemodialysate, Blood Sugar Meter, and Others. The Diagnostic Reagents division provides various diagnostic reagent products and product business related to disease diagnosis, prognosis judgment, and treatment, such as COVID19 diagnostic kits, molecular diagnostics, and immunodiagnostics. The Hemodialysate division includes perfusate for artificial kidney dialysis used in patients with chronic renal failure. The Blood Sugar Meter division offers blood sugar meters, HbA1c, and lipid medical devices. The Others division consists of other home healthcare products such as thermometers and blood pressure monitors. The company was founded on December 30, 2003 and is headquartered in Yongin-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

142280 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company